https://www.selleckchem.com/pr....oducts/FK-506-(Tacro
Finally, both advantages and challenges of EVs as a new drug delivery system are discussed. Here, we encourage researchers to further develop convenient and reliable loading methods for the potential clinical applications of EVs as drug carriers in the future. Secondary lymphedema after surgical interventions is a progressive, chronic disease that is still not completely curable. Over the past years, a multitude of surgical therapy options have been described. To summarize the single-center complications in lymph vessel (LVT
Like
Comment
Share
